Analysis performed in a cohort of over one thousand breast cancer patients showed that Crp2 expression positively correlates with expression of inflammatory genes such as the Urokinase plasminogen activator surface receptor (uPAR), Mmp-2 and Mmp-14 (Hoffmann et al., 2018). This evidence concerns the gene MMP2 and breast cancer.